Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors.
Liposome-encapsulated hemoglobin (LEH), a candidate for red blood cell substitute, is cleared from circulation primarily by the phagocytic system, most likely after opsonization of the vesicles by immunoproteins, particularly complement components. Although modification of LEH by polyethylene glycol (PEG) derivatives prolongs its half-life by blocking the opsonization, the half-life is still short as compared with that of red blood cell components. Therefore, this study was performed to elucidate the opsonin-independent mechanisms that regulate phagocytosis of Neo Red Cell (NRC), a PEG-modified LEH, in culture. PKH67 was used as a fluorescence marker, allowing the quantitation of the phagocytosis of NRC by peripheral blood monocytes plus macrophages. The phagocytosis of PKH67-labeled NRC was inhibited by the addition of an excess of unlabeled NRC, indicating that the phagocytosis of PKH67-labeled NRC is specific to NRC, but not to PKH67. The phagocytosis of NRC was blocked about 70% by anti-CD14, 60% by anti-CD36 and 30% by anti-CD51/61 (vitronectin receptor, alpha(v)beta3). These results provided evidence of an opsonin-independent pathway for the phagocytosis of PEG-modified LEH.
Shibuya-Fujiwara
N
N
Hokkaido Red Cross Blood Center, Sapporo, Japan.
Hirayama
F
F
Ogata
Y
Y
Ikeda
H
H
Ikebuchi
K
K
D015703:Antigens, CD / Q000502:physiology; D018955:CD36 Antigens / Q000502:physiology; D005434:Flow Cytometry; D006454:Hemoglobins / Q000008:administration & dosage / Q000378:metabolism*; D006801:Humans; D039564:Integrin alphaV; D039661:Integrin beta3; D018950:Lipopolysaccharide Receptors / Q000502:physiology; D008081:Liposomes; D008264:Macrophages / Q000276:immunology*; D008565:Membrane Proteins; D009000:Monocytes / Q000276:immunology*; D010587:Phagocytosis; D010980:Platelet Membrane Glycoproteins / Q000502:physiology; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011971:Receptors, Immunologic / Q000502:physiology*; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B
D015703:Antigens, CD; D018955:CD36 Antigens; D006454:Hemoglobins; D039564:Integrin alphaV; D039661:Integrin beta3; D018950:Lipopolysaccharide Receptors; D008081:Liposomes; D008565:Membrane Proteins; D010980:Platelet Membrane Glycoproteins; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; D011092:Polyethylene Glycols